• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEIKAGAKU CORP., TAKAHAGI PLANT GEL-ONE; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEIKAGAKU CORP., TAKAHAGI PLANT GEL-ONE; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Lot Number 0018X05G
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Erythema (1840); Fainting (1847); Rash (2033); Tingling (2171); Dizziness (2194); Anxiety (2328); Confusion/ Disorientation (2553); No Code Available (3191)
Event Date 03/12/2019
Event Type  Injury  
Event Description
Md's notes: per the pt, after leaving the dept feeling numbness in the knee but otherwise in her usual state of health, she began to feel faint after entering her vehicle in the parking garage.The pt elected to return to the dept and while in the elevator, she reports briefly fainting and noted a warm feeling with pins-and-needles throughout her body.She also reports developing a rash.She reports feeling disoriented as to her exact location, although at the time of my interaction, she was alert and oriented to person, place, and time.She was received by a member of the nursing staff and an office mgr, who called 911 due to the pt's change in condition.Md was notified of the pt's return and came immediately to evaluate the pt.The pt appeared out of breath, but reported feeling anxious.The pt was reassured and after several mins of conversation, her breathing pattern normalized.Redness without hives could be seen along the pt's neck and along the antecubital fossa bilaterally.Vital signs obtained by the nurse can be found in the pt's flow chart and were within normal limits.The pt called and spoke with her daughter on the telephone to update her on her status.At this point, first responders arrived to evaluate the pt who was subsequently taken to the emergency dept for further evaluation.Dose or amount: 3 ml millilitre(s); frequency: once a week; route: intra-articular.Diagnosis or reason for use: oa (osteoarthritis) of knee.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GEL-ONE
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
SEIKAGAKU CORP., TAKAHAGI PLANT
MDR Report Key8425102
MDR Text Key139173591
Report NumberMW5084950
Device Sequence Number1
Product Code MOZ
UDI-Device Identifier87541030091
UDI-Public87541-0300-91
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Pharmacist
Type of Report Initial
Report Date 03/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date01/06/2020
Device Lot Number0018X05G
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/14/2019
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Age71 YR
Patient Weight81
-
-